Trials / Completed
CompletedNCT05191056
Anti-aging and Anti-oxidant Efficacy Evaluation of the MelaGene
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- TCI Co., Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of the present study is to evaluate the effects of MelaGene on anti-aging and anti-oxidant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo drink | consume 1 bottle per day for 8 weeks |
| DIETARY_SUPPLEMENT | MelaGene drink | consume 1 bottle per day for 8 weeks |
Timeline
- Start date
- 2021-09-15
- Primary completion
- 2022-01-10
- Completion
- 2022-02-28
- First posted
- 2022-01-13
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05191056. Inclusion in this directory is not an endorsement.